$25.190
-1.191 (-4.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ADPT Prediction & Forecast by Similar Chart Analysis
Alphio's ADPT stock price prediction model matches the current Adaptive Biotechnologies Corporation tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.23 (+0.14%). The 1-week path is $25.67 (+1.90%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Adaptive Biotechnologies Corporation Stock?
Adaptive Biotechnologies Corp is a good buy right now due to its recent revenue growth of 22% year-over-year, reaching $71.6 million, and a strong gross margin of 71.23%. Despite a recent wider net loss of $39.94 million, the company has raised its full-year revenue guidance for its Minimal Residual Disease (MRD) business, which is expected to generate between $268 million and $278 million. The main risk is the high debt to equity ratio of 222.27%, which indicates significant leverage.
ADPT stock price ended at $25.19 on Friday, after losing -4.73%
Adaptive Biotechnologies Corporation (ADPT) last closed at $25.19, losing -4.73%. These facts feed the 1-day and 1-week ADPT price prediction above.
Forecast Drivers
Adaptive Biotechnologies Corporation (ADPT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ADPT, ranked by similarity.
Seasonality analysis for ADPT
Historically the probability of a positive August return for ADPT is 73.02%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ADPT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $8.15 | $9.26 | $11.44 | -63.22% |
| Sep 2026 | $10.29 | $11.11 | $12.39 | -55.89% |
| Oct 2026 | $11.06 | $11.74 | $13.94 | -53.38% |
| Nov 2026 | $8.60 | $9.30 | $10.30 | -63.07% |
| Dec 2026 | $12.64 | $12.70 | $12.80 | -49.57% |
In 2026, Adaptive Biotechnologies Corporation (ADPT) is projected to range from $8.15 to $13.94.
Adaptive Biotechnologies Corporation 2026 monthly forecast
In Aug 2026, Adaptive Biotechnologies Corporation is projected to average $9.26, with a low of $8.15 and high of $11.44.
In Sep 2026, Adaptive Biotechnologies Corporation is projected to average $11.11, with a low of $10.29 and high of $12.39.
In Oct 2026, Adaptive Biotechnologies Corporation is projected to average $11.74, with a low of $11.06 and high of $13.94.
In Nov 2026, Adaptive Biotechnologies Corporation is projected to average $9.30, with a low of $8.60 and high of $10.30.
In Dec 2026, Adaptive Biotechnologies Corporation is projected to average $12.70, with a low of $12.64 and high of $12.80.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.